<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H803098D48AD04C28862439585E7DCFCB" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 3633 IH: Promoting Resources to Expand Vaccination, Education and New Treatments for HPV Cancers Act of 2023</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-05-24</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 3633</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230524">May 24, 2023</action-date><action-desc><sponsor name-id="C001066">Ms. Castor of Florida</sponsor> (for herself, <cosponsor name-id="L000595">Ms. Letlow</cosponsor>, and <cosponsor name-id="S001216">Ms. Schrier</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Public Health Service Act to provide for a public awareness campaign with respect to human papillomavirus, and for other purposes.</official-title></form><legis-body id="HE64E49A0FF254099B8081D87AD8AB8D0" style="OLC"><section id="H1EEB32DCF0694983994B9FB5BC87941D" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Promoting Resources to Expand Vaccination, Education and New Treatments for HPV Cancers Act of 2023</short-title></quote> or the <quote><short-title>PREVENT HPV Cancers Act of 2023</short-title></quote>.</text></section><section id="H92FBCF4E2A874949BA78337EA2D5C1B0" commented="no"><enum>2.</enum><header>Findings</header><text display-inline="no-display-inline">Congress finds the following:</text><paragraph id="H4D4846203E934258BA2B21E05B8C760F" commented="no"><enum>(1)</enum><text display-inline="yes-display-inline">The human papillomavirus (referred to in this Act as <quote>HPV</quote>) causes six different types of cancer (anal, cervical, oropharynx, penile, vaginal, and vulvar).</text></paragraph><paragraph id="H16C856278AA44312B6ABE24954D45185" commented="no"><enum>(2)</enum><text display-inline="yes-display-inline">Approximately 37,300 cases of cancer are caused by HPV each year impacting both women and men. </text></paragraph><paragraph id="H8D4901D3248944B3AC343E4AF6543FDD" commented="no"><enum>(3)</enum><text>About 90 percent of cervical and anal cancers are thought to be caused by HPV.</text></paragraph><paragraph id="H786F92B78D00468BB9F3E67F5A1302CF" commented="no"><enum>(4)</enum><text display-inline="yes-display-inline">Black and Hispanic women are more likely to get HPV-associated cervical cancer than women of other races and ethnicities due to disparities in access to cancer screening and early detection.</text></paragraph><paragraph id="H9ED3A7F74C18442DB16A6AB9CADC9F6D"><enum>(5)</enum><text display-inline="yes-display-inline">New cases of cervical cancer decreased among women in young age groups, likely due to HPV vaccination, but in recent years, new cases of cervical cancer rates among women in older age groups have plateaued or, in the case of women ages 30–34, increased. </text></paragraph><paragraph id="H9544054B50874AAABDDFB3FF9D9A1E29"><enum>(6)</enum><text display-inline="yes-display-inline">Cervical cancer screening has declined and there has been an increase in cervical cancer diagnosed at distant stages, which are more difficult to treat and more likely to recur, leading to greater morbidity and mortality.</text></paragraph><paragraph id="H80DD0E02DBCB487DA3B530E45CBE29D4" commented="no"><enum>(7)</enum><text>Approximately 60 to 70 percent of oropharynx cancer is tied to HPV.</text></paragraph><paragraph id="HFA33084F7802472ABD9754C1B981A640" commented="no"><enum>(8)</enum><text>Most HPV infections that can lead to cancer can be prevented by vaccines. </text></paragraph><paragraph id="H9236A26B9C224D32A08631A046483024" commented="no"><enum>(9)</enum><text display-inline="yes-display-inline">HPV vaccines can also help prevent recurrent respiratory papillomatosis, anal and genital warts.</text></paragraph><paragraph id="H3240CE7BFB784FA0AA5E1EA27C2DBF50" commented="no"><enum>(10)</enum><text>Vaccination for HPV is approved for men and women.</text></paragraph><paragraph id="HC927D63C73234D6EB47381903E3559ED" commented="no"><enum>(11)</enum><text>The vaccines are most effective if administered when an individual is between the ages of 9 and 17.</text></paragraph><paragraph id="HC317E27C2C9346C78FDD2379B52F7BDC" commented="no"><enum>(12)</enum><text display-inline="yes-display-inline">Approximately 60 percent of adolescents have completed the HPV vaccine series. </text></paragraph><paragraph id="HE762275461E943B996AEC166A9321C98" commented="no"><enum>(13)</enum><text display-inline="yes-display-inline">Adolescents living in rural areas continue to be less likely to have initiated and completed the HPV vaccine series than those living in urban areas. </text></paragraph><paragraph id="H191499D05BBC48669EFD743AB61087CC" commented="no"><enum>(14)</enum><text>Health providers’ recommendation of the vaccine is critical to getting adolescents vaccinated.</text></paragraph></section><section id="H9B2CD9CAD8FD4ED49596D0E5218030C1"><enum>3.</enum><header>HPV vaccine public awareness campaign</header><subsection id="H6CC3B5CDAFC445D9A6DD7DB50A1A2E3D"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 317 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247b">42 U.S.C. 247b</external-xref>) is amended by adding at the end the following new subsection:</text><quoted-block id="H194D2B96F17C4C7BA8C7C894C2999563" style="OLC"><subsection id="HA0136005075C45C197F2D851DDC181F7"><enum>(o)</enum><header>HPV vaccine public awareness campaign</header><paragraph id="H49A1E4D3B6584882BF789C0B647D06BF"><enum>(1)</enum><header>In general</header><text>The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall carry out a national campaign to—</text><subparagraph id="HB1BB169B8FD34EE5A7FE05A891A376B2"><enum>(A)</enum><text>increase awareness of the importance of HPV vaccination;</text></subparagraph><subparagraph id="H3077596D4246417B95A3307D3813AFB4"><enum>(B)</enum><text>combat misinformation about HPV vaccination; and</text></subparagraph><subparagraph id="H902CF847914448CA9675D7E428993731"><enum>(C)</enum><text>increase HPV vaccination rates and completion of the vaccine series, especially among males.</text></subparagraph></paragraph><paragraph id="H811E30A29B604084AB32B82D887A4B48"><enum>(2)</enum><header>Consultation</header><text>In carrying out the national campaign required by paragraph (1), the Secretary shall consult with the National Academy of Medicine, including health care providers and public health associations, nonprofit organizations (including those that represent communities most impacted by HPV-associated cancers and communities with low vaccination rates), State and local public health departments, elementary and secondary education organizations (including student and parent organizations), and institutions of higher education, to solicit advice on evidence-based information for policy development and program development, implementation, and evaluation.</text></paragraph><paragraph id="H4282BEF3F5CD4AE381DF5B4061D260C3"><enum>(3)</enum><header>Requirements</header><text>The national campaign required by paragraph (1) shall—</text><subparagraph id="H1223B8751E5E4209A59AC6AC0C17F7E3"><enum>(A)</enum><text>include the use of evidence-based media and public engagement;</text></subparagraph><subparagraph id="H697CAFD49869460E8314D3E8F920C7CA"><enum>(B)</enum><text>be carried out through competitive grants or cooperative agreements awarded to 1 or more private, nonprofit entities with a history developing and implementing similar campaigns;</text></subparagraph><subparagraph id="H382B1ED19395467DAB7D41535BFB2E72"><enum>(C)</enum><text>include the development of culturally and linguistically competent resources that shall be tailored for—</text><clause id="HC91C1EF9BD9D4B2DB89B91368EECD1B9"><enum>(i)</enum><text>communities with high rates of—</text><subclause id="H929FBB6FEA6B4E37A1127FCA667A7DCB"><enum>(I)</enum><text>unvaccinated individuals, including males;</text></subclause><subclause id="HFB0C8BD431CD4B94BBCD613F7BEFD772"><enum>(II)</enum><text>individuals with unique health care needs (such as lesbian, gay, bisexual, transgender, and queer individuals);</text></subclause><subclause id="H6F9D2D72F083490E8A6297B835887E1D"><enum>(III)</enum><text>individuals with high rates of cervical cancer and other HPV-associated cancers (such as Black and Hispanic women); and</text></subclause><subclause id="HBAB15D4BE5DD4B929780974A0F1C70BB"><enum>(IV)</enum><text>populations impacted by the increase in oropharynx cancers;</text></subclause></clause><clause id="H702C1697D6B94B9BB998F0816C01E5C1"><enum>(ii)</enum><text>rural communities; and</text></clause><clause id="HB81110ECC9534CD9838BE3B592AC526B"><enum>(iii)</enum><text>such other communities as the Secretary determines appropriate;</text></clause></subparagraph><subparagraph id="HA9946C0A4F364BBE9D30CF3C25959583"><enum>(D)</enum><text>include the dissemination of HPV vaccination information and communication resources to health care providers and health care facilities (including primary care providers, community health centers, dentists, obstetricians, and gynecologists), and such providers and such facilities for pediatric care, State and local public health departments, elementary and secondary schools, and colleges and universities;</text></subparagraph><subparagraph id="H5842FE238BB442C1B7730749E72D9FA0"><enum>(E)</enum><text>be complementary to, and coordinated with, any other Federal efforts with respect to HPV vaccination;</text></subparagraph><subparagraph id="H7C7A5A27A79C4B398BFD05FD722DB3AE"><enum>(F)</enum><text>include message testing to identify culturally competent and effective messages for behavioral change; and</text></subparagraph><subparagraph id="H238C6F47D60E4ABEB4E378BBD4E2ED7F"><enum>(G)</enum><text>include the award of grants or cooperative agreements to State, local, and Tribal public health departments—</text><clause id="H398157D50D014949AD14E1402B825332"><enum>(i)</enum><text>to engage with communities specified in subparagraph (C), local education agencies, health care providers, community organizations, or other groups the Secretary determines are appropriate to develop and deliver effective strategies to increase HPV vaccination rates; and</text></clause><clause id="H460246D593554A9898FE1684DC4DC537"><enum>(ii)</enum><text>to disseminate culturally and linguistically competent resources on the National Breast and Cervical Cancer Early Detection Program and where an individual can access the screenings locally.</text></clause></subparagraph></paragraph><paragraph id="H95862E371A5C459CBBBC45D2B0CB6D92"><enum>(4)</enum><header>Options for dissemination of information</header><text>The national campaign required by paragraph (1) may—</text><subparagraph id="HE6B415A0F90E4DFCBF0BB17256770CC5"><enum>(A)</enum><text>include the use of—</text><clause id="H48AD694554A546FEAF07EE0B01B63C5E"><enum>(i)</enum><text>social media, television, radio, print, the internet, and other media;</text></clause><clause id="HCAD98B840ACE4D84B3CC2B4C41A54E62"><enum>(ii)</enum><text>in-person or virtual public communications; and</text></clause><clause id="H2DE01BA37D1D4AA88060C2D893AE5BDC"><enum>(iii)</enum><text>recognized, trusted figures;</text></clause></subparagraph><subparagraph id="H84321550EE15428EAAA1448589361EB0"><enum>(B)</enum><text>be targeted to specific groups and communities specified in paragraph (3)(C); and</text></subparagraph><subparagraph id="HA51F3EC4772749A58AD34151372A1971"><enum>(C)</enum><text>include the dissemination of information highlighting each of the following:</text><clause id="H68292EC544A2444EA54AB75DDA26CD13"><enum>(i)</enum><text>Recommended age range to get the HPV vaccine.</text></clause><clause id="HE9C88777B46A441D95257AD5BA31E33C"><enum>(ii)</enum><text>The benefits of getting vaccinated against HPV, including the potential to not acquire HPV-associated cancers.</text></clause><clause id="HD75EE3E0ED89490AB3480FECA69C6FCB"><enum>(iii)</enum><text>HPV vaccine safety and the systems in place to monitor such safety.</text></clause></subparagraph></paragraph><paragraph id="H60B182EBFF5F41A688DDC9CF6981B1A7"><enum>(5)</enum><header>Authorization of appropriations</header><text>There is authorized to be appropriated to carry out this subsection $5,000,000 for each of fiscal years 2024 through 2028.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H19FF3766CF5E41D6882F62C572191BD8"><enum>(b)</enum><header>Report to Congress</header><text>Not later than 2025, the Secretary of Health and Human Services shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor and Pensions of the Senate a report—</text><paragraph id="H85F81A253AB848F88B0B2935D6DB1D93" commented="no"><enum>(1)</enum><text display-inline="yes-display-inline">that contains a qualitative assessment of the campaign under subsection (o) of section 317 of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/247b">42 U.S.C. 247b</external-xref>), as added by subsection (a), and the activities conducted under such campaign; and </text></paragraph><paragraph id="HB4F211899D504342B2BD3AD7676A42D3"><enum>(2)</enum><text display-inline="yes-display-inline">on, with respect to the impact on cancer associated with human papillomavirus, the activities conducted under such subsection (o).</text></paragraph></subsection></section><section id="HA7FBC008153247EAAF30C0541D37904F"><enum>4.</enum><header>Breast and Cervical Cancer Early Detection Program</header><subsection id="H43596970F97A40DC913D4F7689AD161B"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Section 1510(a) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300n-5">42 U.S.C. 300n–5(a)</external-xref>) is amended by striking <quote>and $275,000,000 for fiscal year 2012</quote> and inserting <quote>$275,000,000 for fiscal year 2012, and $300,000,000 for each fiscal years 2024 through 2028</quote>.</text></subsection><subsection id="H2685D8C3D33941AF85F75BDC843E9D76"><enum>(b)</enum><header>Coordinating committee</header><text display-inline="yes-display-inline">Section 1501(d) of the Public Health Service Act (<external-xref legal-doc="usc" parsable-cite="usc/42/300k">42 U.S.C. 300k(d)</external-xref>) is amended—</text><paragraph id="H258E4C5C6E4B4306998DFF89D1E8476F"><enum>(1)</enum><text>in the subsection heading, by striking <quote><header-in-text level="subsection" style="OLC"><enum-in-header>2020</enum-in-header></header-in-text></quote> and inserting <quote><header-in-text level="subsection" style="OLC"><enum-in-header>2030</enum-in-header></header-in-text></quote>; and</text></paragraph><paragraph id="H7628A0D72D11422FA6C72A207382733A"><enum>(2)</enum><text>by striking <quote>2020</quote> and inserting <quote>2025</quote>.</text></paragraph></subsection></section></legis-body></bill> 

